Trial Profile
Effects of liraglutide and empagliflozin add-on to insulin therapy in patients with type 2 diabetes: a randomized controlled study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs Empagliflozin (Primary) ; Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms ELLENA-IT study
- 02 Jun 2020 Status changed from active, no longer recruiting to completed.
- 11 Jun 2019 Results presented at the 79th Annual Scientific Sessions of the American Diabetes Association
- 23 Apr 2019 Status changed from recruiting to active, no longer recruiting.